经肱动脉作为单一或联合入路用于外周动脉疾病复杂介入治疗
本研究回顾性分析2011年3月至2021年4月169例外周动脉疾病患者,经肱动脉单一或联合入路行血管内治疗,评估安全性和有效性。多因素分析显示高血压是肱动脉穿刺点不良事件的独立危险因素(OR 4.76,95%CI 1.33-16.97,P=0.016)。结论认为经肱动脉入路是复杂介入的安全替代选择,并发症随血压控制改善而逐渐减少。
要点
- 169例中87例单一肱动脉入路、82例联合入路,联合组术中支架植入和血管闭合装置更多。
- 高血压是肱动脉穿刺点不良事件的独立危险因素(OR 4.76,95%CI 1.33-16.97,P=0.016)。
- 肱动脉入路并发症26例,其中主要6例(23.1%)、次要20例(76.9%)。
核心结论
- 经肱动脉作为单一或联合入路是外周动脉疾病复杂介入的安全替代选择。
- 肱动脉入路并发症随血压控制改善而逐渐减少。
研究设计与样本
- 回顾性分析2011年3月至2021年4月169例外周动脉疾病患者,经肱动脉单一或联合入路行血管内治疗。
- 采用单因素和多因素分析评估肱动脉穿刺点不良事件的预测因素,数据来自电子病历。
主要发现
- 单一肱动脉入路87例,联合入路82例;联合入路组术中支架植入更多且血管闭合装置使用更多。
- 多因素logistic回归显示高血压是肱动脉穿刺点不良事件的独立危险因素(OR 4.76,95%CI 1.33-16.97,P=0.016)。
- 肱动脉入路部位并发症26例,其中主要6例(23.1%)、次要20例(76.9%)。
- 手动压迫组和血管闭合装置组入路部位并发症分别为21例(16.8%)和5例(11.4%),两组主要或次要并发症发生率无显著差异。
- 血管闭合装置组患者未发生主要入路部位并发症。
临床怎么用
- 经肱动脉作为单一或联合入路可用于外周动脉疾病复杂介入,作者认为其是安全替代选择。
- 作者指出肱动脉入路并发症随血压控制改善而逐渐减少。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to assess the safety and efficacy of the transbrachial approach as a single or combined procedure for complex interventions in peripheral artery disease (PAD). METHODS: Between March 2011 and April 2021, 169 patients with PAD underwent endovascular therapy via the transbrachial approach as a single or dual procedure. Univariate and multivariate analyses were performed to evaluate the predictors of adverse events at the brachial puncture site. All demographic, clinical, and perioperative data were acquired from electronic medical records and retrospectively analyzed. RESULTS: Brachial artery access was used alone and in combination in 87 and 82 patients, respectively. Patients in the combined-approach group underwent more intraoperative stent implantations and had more vascular closure devices (VCD). Multivariate logistic regression analysis revealed that hypertension was an independent factor for higher rates of brachial puncture site adverse events (odds ratio, 4.76; 95% confidence interval, 1.33-16.97; P = 0.016). Brachial artery access-site complications occurred in 26 patients, including 6 (23.1%) major and 20 (76.9%) minor entry-site complications. Entry-site complications were observed in 21 (16.8%) and 5 (11.4%) patients assigned to manual compression and VCD groups, respectively. There were no significant intergroup differences in the incidence of major or minor complications. Interestingly, patients assigned to the VCD group did not experience major entry-site complications. CONCLUSIONS: The transbrachial approach, as a single or combined procedure, is a safe alternative to complex interventions in patients with PAD. Complications of brachial access progressively decrease with improved blood pressure control.
引用
- Wu J, Xu J, Yu Q, et al. Transbrachial Artery as Single or Combined Approach for Complex Interventions in Patients with Peripheral Artery Disease. Ann Vasc Surg. 2023. PMID: 37922962. doi:10.1016/j.avsg.2023.09.093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。